Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries


De Backer G., Jankowski P., Kotseva K., Mirrakhimov E., Reiner Z., Ryden L., ...More

ATHEROSCLEROSIS, vol.285, pp.135-146, 2019 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 285
  • Publication Date: 2019
  • Doi Number: 10.1016/j.atherosclerosis.2019.03.014
  • Title of Journal : ATHEROSCLEROSIS
  • Page Numbers: pp.135-146
  • Keywords: LDL-Cholesterol, Coronary heart disease, EUROASPIRE, Secondary prevention, Dyslipidaemia, Lipid lowering therapy, CLINICAL-PRACTICE, MYOCARDIAL-INFARCTION, RISK-FACTORS, CARDIOVASCULAR OUTCOMES, PREVENTION GUIDELINES, EUROPEAN GUIDELINES, ESC/EAS GUIDELINES, LOWERING THERAPY, STATIN THERAPY, TASK-FORCE

Abstract

Background and aims: One of the objectives of the ESC-EORP EUROASPIRE V survey is to determine how well European guidelines on the management of dyslipidaemias are implemented in coronary patients.